title: Clinical efficacy of new quinolones for therapy of nongonococcal urethritis.
abstract: Ninety-five patients with nongonococcal urethritis were enrolled in a double-blind study and were randomly assigned to a one-week treatment with ciprofloxacin (500 mg twice daily) or ofloxacin (200 mg twice daily). Two weeks after treatment the results obtained for the 79 evaluated patients were as follows: 59 patients (75%) were clinically cured, and of the 54 patients with initial positive cultures, 39 (72%) remained culture-negative. We did not find any statistically significant differences between the results obtained with the two treatments. These results did not vary with the cause. Patient compliance with the regimens of two doses per day was excellent, and no serious adverse effects occurred with either drug.
authors.affiliation: Sexually Transmitted Diseases Clinic, University of Seville Medical School, Spain.
authors.forename: E J
authors.initials: EJ
authors.lastname: Perea
authors.forename: J
authors.initials: J
authors.lastname: Aznar
authors.forename: A
authors.initials: A
authors.lastname: Herrera
authors.forename: J
authors.initials: J
authors.lastname: Mazuecos
authors.forename: A
authors.initials: A
authors.lastname: Rodriguez-Pichardo
mesh_terms: D000328:Adult; D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D009180:Mycoplasmatales Infections / Q000188:drug therapy*; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D011897:Random Allocation; D012008:Recurrence; D014509:Ureaplasma; D014526:Urethritis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D002939:Ciprofloxacin; D015242:Ofloxacin